Clinical Trials Sponsored by Blade Therapeutics
Total 6228 results
-
Blade TherapeuticsNot yet recruitingRESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosis
-
Blade TherapeuticsCompletedDrug Drug InteractionUnited States
-
Blade TherapeuticsCompletedNASH - Nonalcoholic Steatohepatitis | Chronic Liver DiseaseAustralia
-
Blade TherapeuticsCompleted
-
Blade TherapeuticsCompleted
-
Blade TherapeuticsCompletedRelative BioavailabilityAustralia
-
Blade TherapeuticsWithdrawnIdiopathic Pulmonary FibrosisUnited Kingdom
-
Blade TherapeuticsWithdrawn
-
Blade TherapeuticsClinipace WorldwideCompletedCovid19 | Sars-CoV-2United States, Brazil
-
Blaze Bioscience Inc.Completed
-
Blaze Bioscience Inc.CompletedGliomaUnited States, Australia
-
Blaze Bioscience Inc.Completed
-
Crystal Blake-ParlinMaineHealthTerminatedAtrial FibrillationUnited States
-
Blaze Bioscience Australia Pty LtdCompleted
-
University of WashingtonBlaze Bioscience Inc.RecruitingStage III Lip and Oral Cavity Cancer AJCC v8 | Oral Cavity Squamous Cell Carcinoma | Stage I Lip and Oral Cavity Cancer AJCC v8 | Stage II Lip and Oral Cavity Cancer AJCC v8 | Stage IVA Lip and Oral Cavity Cancer AJCC v8United States
-
Blaze Bioscience Inc.National Cancer Institute (NCI)WithdrawnSarcoma, Soft TissueUnited States
-
Nell Blake, DPMTerminatedAnkle Injury | Foot InjuryUnited States
-
Blaze Bioscience Inc.Pacific Pediatric Neuro-Oncology ConsortiumCompletedPediatric Central Nervous System TumorUnited States
-
Blake RaggioUniversity of TorontoUnknownPain, Postoperative | Surgery--Complications | Opioid Use | Opioid Analgesic Adverse ReactionCanada
-
Ranok Therapeutics (Hangzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | DLBCLUnited States
-
John YuBlaze Bioscience Inc.RecruitingCentral Nervous System TumorUnited States
-
Akebia TherapeuticsCyclerion TherapeuticsCompletedType 2 Diabetes Mellitus With Diabetic NephropathyUnited States
-
Akebia TherapeuticsCyclerion TherapeuticsCompletedHeart Failure With Preserved Ejection FractionUnited States, Canada
-
CRISPR Therapeutics AGRecruitingClear Cell Renal Cell Carcinoma | Pancreatic Adenocarcinoma | Cervical Carcinoma | Malignant Pleural Mesothelioma | Esophageal CarcinomaUnited States
-
CRISPR Therapeutics AGActive, not recruitingT Cell LymphomaUnited States, Australia, Canada
-
CRISPR Therapeutics AGActive, not recruitingB-cell Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Adult B Cell ALLUnited States, Spain, Canada, France, Germany, Australia
-
Bacainn Therapeutics, Inc.CompletedHealthy VolunteersUnited States
-
Celsus Therapeutics PLCTerminatedAtopic DermatitisIsrael
-
Eikon TherapeuticsImpact Therapeutics, Inc.RecruitingAdvanced Solid TumorUnited States
-
APRINOIA Therapeutics, LLCActive, not recruitingAlzheimer Disease | Tauopathies | Healthy VolunteersUnited States
-
CRISPR Therapeutics AGActive, not recruitingRenal Cell CarcinomaUnited States, Australia, Canada, Netherlands
-
CRISPR Therapeutics AGRecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Large B-cell Lymphoma | Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)United States
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States
-
CRISPR Therapeutics AGActive, not recruitingMultiple MyelomaUnited States, Spain, Australia, Canada
-
APRINOIA Therapeutics, LLCActive, not recruitingHealthy Volunteers | Alzheimer's Disease | Mild Cognitive Impairment Due to Alzheimer's DiseaseUnited States
-
CRISPR Therapeutics AGViaCyteRecruitingGlucose Metabolism Disorders | Immune System Diseases | Autoimmune Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1 | Metabolic DiseaseCanada
-
iCell Gene TherapeuticsiCar Bio TherapeuticsNot yet recruitingHigh Risk Hematologic Malignancies | Relapsed and/or Refractory Acute Myeloid LeukemiaChina
-
Melinta Therapeutics, LLCRecruitingGram Positive Bacterial InfectionsUnited States
-
TenNor Therapeutics LimitedCompletedGram-Positive Bacterial Infections | Skin and Subcutaneous Tissue Bacterial InfectionsUnited States
-
CRISPR Therapeutics AGViaCyteCompletedGlucose Metabolism Disorders | Immune System Diseases | Autoimmune Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1 | Metabolic DiseaseCanada
-
BlackThorn Therapeutics, Inc.Neumora Therapeutics, Inc.CompletedMajor Depressive DisorderUnited States
-
Sirion Therapeutics, Inc.ReVision Therapeutics, Inc.CompletedGeographic Atrophy | Dry Age Related Macular Degeneration
-
Ractigen Therapeutics.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)Australia
-
NeuShen TherapeuticsNot yet recruiting
-
Monopar TherapeuticsRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Bladder Cancer | Urothelial Carcinoma | Triple-negative Breast Cancer | Solid Tumor, AdultAustralia
-
vTv TherapeuticsNot yet recruitingDiabetes Mellitus, Type 1
-
Enliven TherapeuticsRecruitingColorectal Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2 Amplification | HER2 Positive Solid TumorsUnited States
-
OX2 TherapeuticsRecruitingDiffuse Midline Glioma, H3 K27M-Mutant | Recurrent High Grade GliomaUnited States